At Vivox, our in vitro department stands at the forefront of cutting-edge research and innovation, equipped with state-of-the-art facilities and expertise to drive groundbreaking discoveries. Our dedicated team of scientists utilizes advanced cell culture techniques, molecular assays, and high-throughput screening platforms to conduct comprehensive in vitro studies. From assessing drug efficacy and toxicity to elucidating cellular pathways and mechanisms, we provide tailored solutions to meet the diverse needs of our clients across pharmaceuticals, biotechnology, and academia.
Furthermore, our in vitro department at Vivox offers customizable services and flexible research partnerships, ensuring that each project receives personalized attention and delivers actionable insights. Whether it’s developing novel therapeutics, validating drug candidates, or optimizing experimental protocols, we are committed to delivering high-quality data and scientific excellence that drives progress and innovation in biomedical research. Partner with Vivox’s in vitro experts to accelerate your research and achieve impactful results that pave the way for transformative advancements in healthcare and life sciences.
Cell viability assay
By meticulously addressing cell biology and viability in our research, Vivox ensures the reliability and reproducibility of our findings. This commitment to quality in cell culture and viability assessment enhances the accuracy and relevance of our preclinical studies, ultimately contributing to the development of innovative therapies and solutions for various medical challenges.
Ex-vivo
Ex-vivo studies are an essential component of biomedical research, involving the experimentation or analysis of tissues or cells outside of the living organism. This approach provides valuable insights into biological processes, disease mechanisms, drug effects, and therapeutic interventions in a controlled laboratory environment.
Through ex-vivo studies, Vivox aims to deepen our understanding of biological processes, advance drug discovery and development, and ultimately improve patient outcomes. Our expertise in ex-vivo techniques and rigorous experimental protocols ensure the reliability and relevance of our research findings in various biomedical fields.
Immunoassays
In Vivox's in vitro department, immunoassay capabilities are at the forefront of our research endeavors. Leveraging state-of-the-art technologies and expertise, we conduct a wide range of immunoassays to assess biomarkers, cytokines, hormones, and other analytes critical for understanding immune responses and disease mechanisms. Our team utilizes various immunoassay platforms, including ELISA, multiplex assays, and flow cytometry, to provide precise and reliable quantification of analytes in biological samples. With a focus on accuracy, sensitivity, and robustness, Vivox's immunoassay services empower researchers and clients to unravel complex immunological processes, evaluate drug efficacy, and advance therapeutic development in a diverse range of fields, from immunology and oncology to neurology and metabolic disorders.
Proteins
Vivox's in vitro department excels in protein analysis, utilizing cutting-edge techniques to study the structure, function, and interactions of proteins. With expertise in protein purification, characterization, and quantification, we enable comprehensive investigations into protein-based mechanisms underlying biological processes and disease pathways. Our team employs state-of-the-art technologies such as Western blotting, immunoprecipitation, mass spectrometry, and protein-protein interaction assays to provide valuable insights into protein behavior and dynamics. Whether it's elucidating signaling pathways, validating drug targets, or optimizing protein-based assays, Vivox's protein expertise drives impactful discoveries and advances in biomedical research and therapeutic development.
Molecular biology
Vivox's in vitro department harnesses the power of molecular biology techniques to delve deep into cellular processes and molecular mechanisms. Our skilled scientists employ a range of molecular biology tools, including PCR, gene expression analysis, gene editing technologies like CRISPR-Cas9, and RNA interference (RNAi) approaches, to elucidate genetic and molecular pathways underlying disease states and therapeutic targets. Our expertise extends to molecular cloning, recombinant DNA technology, and functional genomics, allowing us to engineer cell lines, express proteins of interest, and conduct comprehensive molecular analyses. With a focus on precision, reliability, and innovation, Vivox's molecular biology capabilities drive transformative advancements in understanding biological systems and developing targeted interventions for improved health outcomes.
FACS
FACS, or Fluorescence-Activated Cell Sorting, is a powerful technique used to analyze and sort cells based on their fluorescent properties. It allows researchers to isolate specific cell populations, assess cell viability, and study cellular characteristics at a single-cell level, contributing significantly to cell biology research and therapeutic development.
Vivox collaborate with Almog Diagnotics with executing high level FACS analysing.
Almog’s flow cytometry services include:
- Antibody panel design by highly experienced specialists
- Experiment setup
- Tissue dissociation with our advanced GentleMACS
- Multi-color samples staining up to 35 fluorochromes in one tube
- Samples acquisition on our advanced Flow Cytometers
- High throughput up to 96 well plates
- Full and detailed report of samples analysis
